Cardiometabolic Health Congress (CMHC)
Avatar

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

By Cardiometabolic Health Congress (CMHC) FEATURING Lance Sloan
June 17, 2019
2 Comments
Login to view comments. Click here to Login

Featured Video

01:52
Novo Nordisk – GLP-1 RA Therapy

T2D Treatment After Oral Agents: What Is the Next Step?

Feat. C. Wierum, L. Coco

Featured Video

08:56
Novo Nordisk – GLP-1 RA Therapy

Reaching A1C Goals With GLP-1 RA Injectables: What Does This Trial D…

Feat. R. Pratley

Related Content

AUTOPLAY
06:38
Allan Jaffe

What Does Elevated Troponin Mean in COVID-19?

64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo
15:33
Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

21:19
Patricia Kao

Cardio-Renal Syndrome Management: What Are the Key Factors That Impa…

20:30
Jennifer Reynolds

New Treatments for SLE

19:30
Nasrien Ibrahim

Hot Topics in Heart Failure ACC.22

12:23
American Heart & Vascular Institute

SGLT2 Inhibitors for HF: Is this Therapy Helpful for Reducing the Ho…

Feat. M. Tipton
10:02
Emory Diabetes Education Training Academy

Insulin Treatment in Patients with Type 2 Diabetes: When to Use Comb…

Feat. G. Umpierrez
13:42
George Bakris

Current Status of Prevention and Treatment of Diabetic Nephropathy

11:50
American Heart & Vascular Institute

New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …

Feat. M. Kittleson
17:35
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2…

Feat. B. Greenberg
17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

08:29
UChicago Medicine

Decreasing Barriers and Increasing Access for Living Organ Donation

Feat. C. Maynard
15:25
Javed Butler

SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus

23:24
Scripps Health

The Future of Kidney Disease (With a Nod to the Present)

Feat. T. Henke
23:34
Cedars Sinai

New Approaches and Therapies for Weight Management and CVD Risk

Feat. S. Campa
09:24
Mount Sinai Advanced Innovations in Heart Failure

Heart Failure With Preserved Ejection Fraction: Role of SGLT2 Inhibi…

Feat. J. Badimon
11:45
Cedars Sinai

SGLT2i and Heart Failure

Feat. M. Kittleson